Cargando…

Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015

BACKGROUND: Although antimicrobial resistance is increasingly common in equine medicine, molecular and epidemiological data remains scarce. OBJECTIVES: We estimated the prevalence of, and risk factors for, shedding of multidrug resistant (MDR), extended spectrum β‐lactamase (ESBL)‐producing, and Amp...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lagarde, Maud, Larrieu, Caroline, Praud, Karine, Schouler, Catherine, Doublet, Benoît, Sallé, Guillaume, Fairbrother, John M., Arsenault, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430864/
https://www.ncbi.nlm.nih.gov/pubmed/30648296
http://dx.doi.org/10.1111/jvim.15415
_version_ 1783405834470948864
author de Lagarde, Maud
Larrieu, Caroline
Praud, Karine
Schouler, Catherine
Doublet, Benoît
Sallé, Guillaume
Fairbrother, John M.
Arsenault, Julie
author_facet de Lagarde, Maud
Larrieu, Caroline
Praud, Karine
Schouler, Catherine
Doublet, Benoît
Sallé, Guillaume
Fairbrother, John M.
Arsenault, Julie
author_sort de Lagarde, Maud
collection PubMed
description BACKGROUND: Although antimicrobial resistance is increasingly common in equine medicine, molecular and epidemiological data remains scarce. OBJECTIVES: We estimated the prevalence of, and risk factors for, shedding of multidrug resistant (MDR), extended spectrum β‐lactamase (ESBL)‐producing, and AmpC β‐lactamase‐producing, or some combination of these in Escherichia coli in horses in France. We characterized ESBL/AmpC isolates for antimicrobial susceptibility and the presence of virulence and ESBL/AmpC‐associated resistance genes. ANIMALS: Fecal samples from healthy adult horses at 41 premises were collected. A questionnaire was completed by each premises manager. A subset of these samples was tested to build 2 bacterial collections. METHODS: Indicator (without enrichment) and specific (enrichment with ceftriaxone) E. coli tested for antimicrobial susceptibility. Prevalence of isolates nonsusceptible to antimicrobials was estimated at the horse and the premises level. The ESBL/AmpC and virulence genes were identified by PCR. Multivariable logistic regression was used to investigate risk factors for MDR and ESBL/AmpC isolates at premises. RESULTS: Approximately 44% of horses shed MDR E. coli. Resistance most commonly was observed to ampicillin, streptomycin, and amoxicillin/clavulanic acid. Twenty‐nine percent of premises housed horses shedding ESBL/AmpC‐producing isolates. The ESBL/AmpC gene most commonly identified was bla (CTX‐M‐1). Virulence gene iutA was identified in 1 ESBL/AmpC‐producing isolate. Medical treatment, staff numbers, and activity were identified as risk factors for housing horses shedding ESBL/AmpC‐producing E. coli isolates. CONCLUSIONS AND CLINICAL IMPORTANCE: Prevalence of healthy horses harboring ESBL/AmpC genes and MDR isolates in their intestinal microbiota is substantial. Risk factors could be used to elaborate guidelines to prevent their dissemination.
format Online
Article
Text
id pubmed-6430864
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-64308642019-04-04 Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015 de Lagarde, Maud Larrieu, Caroline Praud, Karine Schouler, Catherine Doublet, Benoît Sallé, Guillaume Fairbrother, John M. Arsenault, Julie J Vet Intern Med EQUID BACKGROUND: Although antimicrobial resistance is increasingly common in equine medicine, molecular and epidemiological data remains scarce. OBJECTIVES: We estimated the prevalence of, and risk factors for, shedding of multidrug resistant (MDR), extended spectrum β‐lactamase (ESBL)‐producing, and AmpC β‐lactamase‐producing, or some combination of these in Escherichia coli in horses in France. We characterized ESBL/AmpC isolates for antimicrobial susceptibility and the presence of virulence and ESBL/AmpC‐associated resistance genes. ANIMALS: Fecal samples from healthy adult horses at 41 premises were collected. A questionnaire was completed by each premises manager. A subset of these samples was tested to build 2 bacterial collections. METHODS: Indicator (without enrichment) and specific (enrichment with ceftriaxone) E. coli tested for antimicrobial susceptibility. Prevalence of isolates nonsusceptible to antimicrobials was estimated at the horse and the premises level. The ESBL/AmpC and virulence genes were identified by PCR. Multivariable logistic regression was used to investigate risk factors for MDR and ESBL/AmpC isolates at premises. RESULTS: Approximately 44% of horses shed MDR E. coli. Resistance most commonly was observed to ampicillin, streptomycin, and amoxicillin/clavulanic acid. Twenty‐nine percent of premises housed horses shedding ESBL/AmpC‐producing isolates. The ESBL/AmpC gene most commonly identified was bla (CTX‐M‐1). Virulence gene iutA was identified in 1 ESBL/AmpC‐producing isolate. Medical treatment, staff numbers, and activity were identified as risk factors for housing horses shedding ESBL/AmpC‐producing E. coli isolates. CONCLUSIONS AND CLINICAL IMPORTANCE: Prevalence of healthy horses harboring ESBL/AmpC genes and MDR isolates in their intestinal microbiota is substantial. Risk factors could be used to elaborate guidelines to prevent their dissemination. John Wiley & Sons, Inc. 2019-01-15 2019 /pmc/articles/PMC6430864/ /pubmed/30648296 http://dx.doi.org/10.1111/jvim.15415 Text en © 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle EQUID
de Lagarde, Maud
Larrieu, Caroline
Praud, Karine
Schouler, Catherine
Doublet, Benoît
Sallé, Guillaume
Fairbrother, John M.
Arsenault, Julie
Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title_full Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title_fullStr Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title_full_unstemmed Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title_short Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015
title_sort prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β‐lactamase/ampc β‐lactamase producing escherichia coli in healthy horses in france in 2015
topic EQUID
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430864/
https://www.ncbi.nlm.nih.gov/pubmed/30648296
http://dx.doi.org/10.1111/jvim.15415
work_keys_str_mv AT delagardemaud prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT larrieucaroline prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT praudkarine prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT schoulercatherine prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT doubletbenoit prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT salleguillaume prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT fairbrotherjohnm prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015
AT arsenaultjulie prevalenceriskfactorsandcharacterizationofmultidrugresistantandextendedspectrumblactamaseampcblactamaseproducingescherichiacoliinhealthyhorsesinfrancein2015